NO20030443D0 - Fremgangsmåte for fremstilling av funksjonelle proteindomener - Google Patents

Fremgangsmåte for fremstilling av funksjonelle proteindomener

Info

Publication number
NO20030443D0
NO20030443D0 NO20030443A NO20030443A NO20030443D0 NO 20030443 D0 NO20030443 D0 NO 20030443D0 NO 20030443 A NO20030443 A NO 20030443A NO 20030443 A NO20030443 A NO 20030443A NO 20030443 D0 NO20030443 D0 NO 20030443D0
Authority
NO
Norway
Prior art keywords
preparation
functional protein
protein domains
domains
functional
Prior art date
Application number
NO20030443A
Other languages
English (en)
Other versions
NO20030443L (no
NO330897B1 (no
Inventor
Paul William Chapman
Giampiero De Luca
Luca Falciola
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20030443D0 publication Critical patent/NO20030443D0/no
Publication of NO20030443L publication Critical patent/NO20030443L/no
Publication of NO330897B1 publication Critical patent/NO330897B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
NO20030443A 2000-08-01 2003-01-28 Fremgangsmate for fremstilling av et protein, der proteinet er et fragment av et protein som er et primaert translatertprodukt av et malgen som enten er C- eller N-terminalen idet primaere translaterte produkt fra et malgen, og derfragmentet har en biologisk funksjon NO330897B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0018876.3A GB0018876D0 (en) 2000-08-01 2000-08-01 Method of producing polypeptides
PCT/GB2001/003455 WO2002010372A1 (en) 2000-08-01 2001-08-01 Method of producing functional protein domains

Publications (3)

Publication Number Publication Date
NO20030443D0 true NO20030443D0 (no) 2003-01-28
NO20030443L NO20030443L (no) 2003-03-25
NO330897B1 NO330897B1 (no) 2011-08-08

Family

ID=9896767

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030443A NO330897B1 (no) 2000-08-01 2003-01-28 Fremgangsmate for fremstilling av et protein, der proteinet er et fragment av et protein som er et primaert translatertprodukt av et malgen som enten er C- eller N-terminalen idet primaere translaterte produkt fra et malgen, og derfragmentet har en biologisk funksjon

Country Status (21)

Country Link
US (1) US8048645B2 (no)
EP (1) EP1305411B1 (no)
JP (1) JP5068916B2 (no)
CN (1) CN1468304B (no)
AR (1) AR031717A1 (no)
AT (1) ATE398174T1 (no)
AU (1) AU7573901A (no)
BR (1) BR0112979A (no)
CA (1) CA2415768C (no)
CY (1) CY1110431T1 (no)
DE (1) DE60134410D1 (no)
DK (1) DK1305411T3 (no)
ES (1) ES2305091T3 (no)
GB (1) GB0018876D0 (no)
HK (1) HK1059281A1 (no)
IL (1) IL154212A0 (no)
NO (1) NO330897B1 (no)
PT (1) PT1305411E (no)
SI (1) SI1305411T1 (no)
WO (1) WO2002010372A1 (no)
ZA (1) ZA200300827B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60312039T2 (de) * 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
AU2004245175C1 (en) * 2003-06-10 2010-03-18 Biogen Ma Inc. Improved secretion of neublastin
WO2008027558A2 (en) 2006-08-31 2008-03-06 Codon Devices, Inc. Iterative nucleic acid assembly using activation of vector-encoded traits
WO2011053957A2 (en) * 2009-11-02 2011-05-05 Gen9, Inc. Compositions and methods for the regulation of multiple genes of interest in a cell
WO2012064975A1 (en) 2010-11-12 2012-05-18 Gen9, Inc. Protein arrays and methods of using and making the same
ES2548400T3 (es) 2010-11-12 2015-10-16 Gen9, Inc. Métodos y dispositivos para la síntesis de ácidos nucleicos
EP2944693B1 (en) 2011-08-26 2019-04-24 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
EP4001427A1 (en) 2012-04-24 2022-05-25 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
JP6509727B2 (ja) 2012-06-25 2019-05-15 ギンゴー バイオワークス， インコーポレイテッド 核酸アセンブリおよび高処理シークエンシングのための方法
TWI721929B (zh) 2013-08-05 2021-03-11 美商扭轉生物科技有限公司 重新合成之基因庫
CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016126987A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
IL258164B (en) 2015-09-18 2022-09-01 Twist Bioscience Corp Methods to regulate the activity of proteins and cells and a method for the production of nucleic acids
WO2017053450A1 (en) 2015-09-22 2017-03-30 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
CN108603307A (zh) 2015-12-01 2018-09-28 特韦斯特生物科学公司 功能化表面及其制备
WO2018038772A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
JP6871364B2 (ja) 2016-09-21 2021-05-12 ツイスト バイオサイエンス コーポレーション 核酸に基づくデータ保存
EA201991262A1 (ru) 2016-12-16 2020-04-07 Твист Байосайенс Корпорейшн Библиотеки вариантов иммунологического синапса и их синтез
SG11201907713WA (en) 2017-02-22 2019-09-27 Twist Bioscience Corp Nucleic acid based data storage
EP3595674A4 (en) 2017-03-15 2020-12-16 Twist Bioscience Corporation BANKS OF VARIANTS OF IMMUNOLOGICAL SYNAPSE AND THEIR SYNTHESIS
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
CN111566209A (zh) 2017-06-12 2020-08-21 特韦斯特生物科学公司 无缝核酸装配方法
US11407837B2 (en) 2017-09-11 2022-08-09 Twist Bioscience Corporation GPCR binding proteins and synthesis thereof
KR20240024357A (ko) 2017-10-20 2024-02-23 트위스트 바이오사이언스 코포레이션 폴리뉴클레오타이드 합성을 위한 가열된 나노웰
US10936953B2 (en) 2018-01-04 2021-03-02 Twist Bioscience Corporation DNA-based digital information storage with sidewall electrodes
KR20210013128A (ko) 2018-05-18 2021-02-03 트위스트 바이오사이언스 코포레이션 핵산 하이브리드화를 위한 폴리뉴클레오타이드, 시약 및 방법
SG11202109283UA (en) 2019-02-26 2021-09-29 Twist Bioscience Corp Variant nucleic acid libraries for antibody optimization
AU2020229349A1 (en) 2019-02-26 2021-10-14 Twist Bioscience Corporation Variant nucleic acid libraries for GLP1 receptor
EP3987019A4 (en) 2019-06-21 2023-04-19 Twist Bioscience Corporation BARCODE-BASED NUCLEIC ACID SEQUENCE ARRANGEMENT
WO2022067214A2 (en) 2020-09-28 2022-03-31 Vestaron Corporation Mu-diguetoxin-dc1a variant polypeptides for pest control
CA3217862A1 (en) 2021-05-05 2022-11-10 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
EP0747485B1 (en) * 1989-11-06 1998-12-02 Cell Genesys, Inc. Production of proteins using homologous recombination
JP3501286B2 (ja) 1989-12-22 2004-03-02 アプライド リサーチ システムズ，エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
WO1993004169A1 (en) * 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
US5545817A (en) * 1994-03-11 1996-08-13 Calgene, Inc. Enhanced expression in a plant plastid
WO1997023244A1 (en) 1995-12-22 1997-07-03 Smithkline Beecham Corporation Use of antisene oligodeoxynucleotides to produce truncated proteins
WO1999015650A1 (en) 1997-09-26 1999-04-01 Athersys, Inc. Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
US7063960B2 (en) * 1997-12-12 2006-06-20 The Rockefeller University Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
JP3725782B2 (ja) * 1998-03-27 2005-12-14 レキシコン ジェネティックス インコーポレーテッド 遺伝子突然変異誘発および遺伝子発見のためのベクター
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
JP3688118B2 (ja) * 1998-05-22 2005-08-24 独立行政法人科学技術振興機構 遺伝子トラップ用ベクターと、このベクターを用いた遺伝子トラップ方法

Also Published As

Publication number Publication date
DE60134410D1 (de) 2008-07-24
ATE398174T1 (de) 2008-07-15
EP1305411B1 (en) 2008-06-11
BR0112979A (pt) 2003-07-08
NO20030443L (no) 2003-03-25
JP2004504840A (ja) 2004-02-19
CY1110431T1 (el) 2015-04-29
EP1305411A1 (en) 2003-05-02
US8048645B2 (en) 2011-11-01
HK1059281A1 (en) 2004-06-25
CN1468304A (zh) 2004-01-14
AR031717A1 (es) 2003-10-01
ES2305091T3 (es) 2008-11-01
NO330897B1 (no) 2011-08-08
GB0018876D0 (en) 2000-09-20
SI1305411T1 (sl) 2008-10-31
DK1305411T3 (da) 2008-09-01
WO2002010372A8 (en) 2002-02-28
ZA200300827B (en) 2004-02-25
CA2415768A1 (en) 2002-02-07
WO2002010372A1 (en) 2002-02-07
PT1305411E (pt) 2008-07-03
CN1468304B (zh) 2011-01-19
IL154212A0 (en) 2003-07-31
JP5068916B2 (ja) 2012-11-07
CA2415768C (en) 2011-05-17
US20040053362A1 (en) 2004-03-18
AU7573901A (en) 2002-02-13

Similar Documents

Publication Publication Date Title
NO20030443D0 (no) Fremgangsmåte for fremstilling av funksjonelle proteindomener
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
FI20011622A0 (fi) Menetelmä sitalopraamin valmistamiseksi
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
DE60117106D1 (de) Verfahren zur Herstellung von Halopropyldimethylchlorosilanen
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
DE60026607T8 (de) Verfahren zur Herstellung von Perfluoralkadienen
DE60035109D1 (de) Verfahren zur herstellung von thiamethoxam
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20026155L (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20023606D0 (no) Kombinatorielle proteindomener
NO993949D0 (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20024887D0 (no) Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
DE50013395D1 (de) Verfahren zur Herstellung von ÄIrCODClÜ2
DE60120139D1 (de) Verfahren zur herstellung von camptothectin
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MM1K Lapsed by not paying the annual fees